Preclinical study of human umbilical cord mesenchymal stem cell sheets for the recovery of ischemic heart tissue.

Allogeneic source and cell bank established by the standard operation process and quality control make hUC-MSCs sheet possible to treat MI by off-the-shelf drug with universal quality instead of individualized medical technology.